key: cord-0975682-j53k0giw
authors: Bhatia, Rohit; Sylaja, P.N.; Srivastava, M.V. Padma; Komakula, Snigdha; Iype, Thomas; Parthasarathy, Rajsrinivas; Khurana, Dheeraj; Pardesani, Vibhor; Pamidimukkala, Vijaya; Kumaravelu, S.; Pandian, Jeyaraj; Kushwaha, Suman; Chowdhury, Debashish; Gupta, Salil; Rajendran, Srijithesh P.; Reddy, Rajshekar; Roy, Jayanta; Sharma, Arvind; Nambiar, Vivek; Rai, Nirendra Kumar; Upadhyay, Ashish Datt; Parkipandla, Satish; Singh, Mamta Bhushan; Vibha, Deepti; Vishnu, Venugopalan Y.; Rajan, Roopa; Gupta, Anu; Pandit, Awadh Kishore; Agarwal, Ayush; Gaikwad, Shailesh B.; Garg, Ajay; Joseph, Leve; Sreedharan, Sapna Erat; Reddy, Sritheja; Sreela, Krishna; Ramachandran, Dileep; George, Githin Benoy; Panicker, Praveen; Suresh, M.K.; Gupta, Vipul; Ray, Sucharita; Suri, Vikas; Ahuja, Chirag; Kajal, Kamal; Lal, Vivek; Singh, Rakesh K.; Oza, Harsh; Halani, Hiral; Sanivarapu, Srinivasareddy; Sahonta, Rajeswar; Duggal, Ashish; Dixit, Prashant; Kulkarni, Girish Baburao; Taallapalli, A.V.R.; Parmar, Mamta; Chalasani, Vamsi; Kashyap, Manshi
title: Clinical profile and outcome of non-COVID strokes during pandemic and the pre pandemic period: COVID-Stroke Study Group (CSSG) India
date: 2021-07-16
journal: J Neurol Sci
DOI: 10.1016/j.jns.2021.117583
sha: 512b30b9e3a8eee716a20984eea5d4fc0f9530d1
doc_id: 975682
cord_uid: j53k0giw

BACKGROUND: As the health systems around the world struggled to meet the challenges of COVID-19 pandemic, care of many non-COVID emergencies was affected. AIMS: The present study examined differences in the diagnosis, evaluation and management of stroke patients during a defined period in the ongoing pandemic in 2020 when compared to a similar epoch in year 2019. METHODS: The COVID stroke study group (CSSG) India, included 18 stroke centres spread across the country. Data was collected prospectively between February and July 2020 and retrospectively for the same period in 2019. Details of demographics, stroke evaluation, treatment, in-hospital and three months outcomes were collected and compared between these two time points. RESULTS: A total of 2549 patients were seen in both study periods; 1237 patients (48.53%) in 2019 and 1312 (51.47%) in 2020. Although the overall number of stroke patients and rates of thrombolysis were comparable, a significant decline was observed in the month of April 2020, during the initial period of the pandemic and lockdown. Endovascular treatment reduced significantly and longer door to needle and CT to needle times were observed in 2020. Although mortality was higher in 2020, proportion of patients with good outcome were similar in both the study periods. CONCLUSIONS: Although stroke admissions and rates of thrombolysis were comparable, some work flow metrics were delayed, endovascular stroke treatment rates declined and mortality was higher during the pandemic study period. Reorganization of stroke treatment pathways during the pandemic has likely improved the stroke care delivery across the globe.

The COVID-19 pandemic has affected healthcare around the world. On 11 March 2020, the World Health Organization declared a global pandemic as COVID-19 hospitalizations and emergency medical system activations increased. During its peak, stroke admissions and care were significantly affected as the health systems were overwhelmed with the management of patients affected with COVID-19. The impact was significant on the non-COVID-19 emergency profile.

[1] Systems needed reorganization to balance care of non-COVID cases as well as protection of health care workers.

Studies reported a decline in the rates of stroke hospitalizations and the proportion of patients receiving reperfusion therapies like intravenous thrombolysis and/or mechanical thrombectomy for acute ischemic stroke. [2] [3] [4] One study from Europe showed a sharp drop in non-COVID-19 related CT scans done during the pandemic period when compared with a similar period in 2019. [5] Also, disruption of routine health services and medical supplies resulted in increased morbidity and avoidable mortality in patients with non-communicable diseases. [6] A questionnaire-based survey conducted among neurologists in 13 major centers of India showed a 61.22% reduction in weekly stroke cases during the lockdown period . [7] In a study from Belgium, primary care providers observed disruption in the delivery of chronic care for conditions like diabetes and hypertension during the COVID-19

pandemic. [8] Individuals with multimorbidity (43%) reported more challenges compared to those with single condition (35%). [9] The most challenging issue was physician consultation J o u r n a l P r e -p r o o f followed by diagnostic investigations (26%). Transport logistics (33%), financial arrangements (26%), mobility-restrictions (21%), and fear of going to hospital owing to the risk of contagion (18%) were other prominent reported factors. [9] There was evidence of fall in screening tests for diabetes and dyslipidemia during months of February, March 2020 with modest rebound in early April 2020.

[10] These preventive services, routine monitoring, and treatment of lipid disorders and diabetes may have both short and longterm consequences. It is therefore essential to observe how the COVID pandemic influenced care of acute stroke patients.

The current study aims to examine whether COVID-19 pandemic affected the management of stroke patients. We aimed to observe differences if any in the rate of stroke admissions, acute stroke management including thrombolysis or thrombectomy, stroke metrics, etiological evaluation, morbidity, and mortality between the stroke patients seen during the period of ongoing COVID-19 pandemic between February and July 2020 and a similar epoch in the year 2019.

The COVID stroke study group (CSSG) India included 18 stroke centers spread across east, west, north and south of the country. This study had a retrospective as well as a prospective component. The study was approved by the institutional ethics committee. Written informed consent was taken from the patients or their legally authorized representative. Stroke data was prospectively collected for the period between February 2020 to July 2020. The retrospective data between February 2019 and July 2019 was collected from in-hospital patient records. All admitted acute stroke patients were included. Details of total stroke J o u r n a l P r e -p r o o f Journal Pre-proof patients seen, monthly stroke admissions, demographics, type of stroke, treatment details, interventions, duration of stay, investigations, subtyping of ischemic stroke, in hospital complications, mortality and three months outcome on the modified Rankin score (mRS) were analyzed. Details of timings including door to CT, CT to needle, door to needle, onset to needle (for patients undergoing thrombolysis) and CT to puncture time, recanalization and total procedure time (among patients undergoing endovascular treatment ) were recorded.

Three months mRS was prospectively collected telephonically for patients seen in 2020 and retrospectively retrieved from either the database maintained by stroke centers or assessed from medical records for the year 2019. Data that was available was included in the final analysis. Data was presented as mean (SD) or median (IQR) and frequency(%). Continuous variables were compared using students t test (following normal distributions) or Wilcoxon's rank sum test ( Non-normal distribution). Qualitative variables were compared using Chisquare/Fisher's exact test. A two-tailed p value of <= 0.05 was considered as significant.

Adjusted p values (q value) for comparisons between different variables during the two periods of the study were generated using Benjamini-Hochberg procedure. q values < 0.05 were considered significant.Stata version14 (StataCorp, Lakeway Drive College Station, Texas, USA) was used for analysis.

A total of 2549 patients were seen in both study periods; 1237 patients (48.53%) in year 2019 and 1312 (51.47%) in the year 2020. Although overall monthly stroke frequency did not reflect any specific trend, a sharp decline in stroke admissions was observed in the month of April 2020, which seemed to improve and stabilize by July 2020 ( Figure 1A 

The present study did not find any difference in the total number of stroke admissions between the two study periods although a decline in the April 2020 correlated with the [16] Interestingly, contrary to what was perceived and has been observed previously, the overall rate of thrombolysis was not changed during the pandemic period. [17] However, as mentioned above, the sharp decline in thrombolysis in April 2020 correlates well with the reduction of stroke admissions during the sudden surge of COVID-19 cases, lockdowns and overwhelmed health care facilities. [18] As most of the sites in the present study are established stroke centres, it is likely that acute stroke management remained a priority and reorganization of care pathways during the pandemic stabilized the rate of stroke admissions and thrombolysis. [19] However, higher door to needle and CT to needle times do suggest a possible delay during the screening process in the emergency department or systems being reorganised to optimise treatments in the emergency. This could also reflect a possible influence of risk concerns and delay in acceptance by the patient/families to consent for thrombolysis during the pandemic period. [20] A significant reduction in rates of EVT was observed. As reported in other countries as well, EVT may have declined due to stricter screening guidelines, concerns of COVID risk to the health care workers, apprehension of interventional teams in the absence of RTPCR (Real Time Polymerase Chain reaction) reports ( as it takes few hours), overwhelmed health care systems for COVID care, delay in interhospital transfer etc. [21] [22] [23] For such reasons, protected stroke code was introduced as a concept. [24] Guidelines and recommendations were made to continue comprehensive stroke treatment by system changes and strengthening the spokes in a hub and spoke model to maintain work flow metrics. [25] [26] [27] [28] Reorganization of services evolved with time. In a survey conducted among the study sites, designated COVID positive and negative zones were established in the emergency. A protected stroke code was initiated and majority of the centres started rapid triaging of stroke patients through a separate stroke corridor. Limited centers also maintained a dedicated imaging for COVID patients and CT lung was parallelly performed as an add on screening J o u r n a l P r e -p r o o f tool. Although most centres thrombolysed without mandatory COVID testing, some centres used Rapid Antigen test for screening. However, COVID testing was mandatory before thrombectomy, preferably by using Rapid antigen test in most sites.

To maintain optimum care for non-COVID emergencies, a second triage using a more inclusive, dynamic checklist and a mandatory holding in the system-specific in-patient area was helpful among one of the study sites. [29] A reduction in number of investigations during the pandemic period is likely due to the concerns of increased patient movement within the hospital and risk of COVID exposure and vice versa. It is possible that the focus was on providing optimum acute care and shortening the hospital stay. During the lockdown period, in hospitals where COVID care was also being provided, specialized investigations were limited to patients who needed them most. Reorganization of health systems, however did improve the overall care of stroke patients. [30] Higher mortality was observed in the pandemic study period. Published observations suggest both an increase in mortality during the pandemic period and no significant change. [31] [32] [33] However, a higher number of patients with missing information in 2019 may have caused an imbalance in results. Many factors could potentially contribute to this observation including delayed patient arrivals to the hospital, delayed in-hospital treatment, decline in use of EVT for LVO (Large Vessel Occlusion) patients, increased in-hospital complications, suboptimum rehabilitation and home care by the family members (although data was not explicitly collected for this) and inadequate follow up. Family members may have had difficulty bringing patients to the hospitals during the peak of pandemic and lockdown period as routine outpatient department care was affected. However, reorganization of health systems from established stroke centre showed that outcomes and workflow metrics were preserved even during the pandemic. [2, 30] Improvement in stroke admissions and thrombolysis rates after April 2020 in the present study could also reflect a similar phenomenon. J o u r n a l P r e -p r o o f 

Underutilization of health care for strokes during the COVID-19 outbreak

Non-COVID-19 emergencies: where have all the patients gone?

Prevention and control of non-communicable diseases in the COVID-19 response

COVID-19 pandemic and challenges in stroke care in India

The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium

Managing Multimorbidity (Multiple Chronic Diseases) Amid COVID-19 Pandemic: A Community Based Study 11

The effect of the COVID-19 pandemic on emergency department visits for serious cardiovascular conditions

Decreased Stroke, Acute Coronary Syndrome, and Corresponding Interventions at 65 US Hospitals Following COVID-19

Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era

Stroke care during the COVID-19 pandemic: experience from three large European countries

Exploring the Collateral Damage of the COVID-19 Pandemic on Stroke Care

COVID-19: Stroke Admissions, Emergency Department Visits

Effect of COVID-19 on Emergent Stroke Care: A Regional Experience

Maintenance of Acute Stroke Care Service During the COVID-19 Pandemic Lockdown

Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study

Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke

Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak: Decreased Activity, and Increased Care Delays

Management of Acute Ischemic Stroke in the Interventional Neuroradiology Suite During the COVID-19 Pandemic: A Global Survey

Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy? Stroke

Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic

Consensus Statement -Suggested Recommendations for Acute Stroke Management during the COVID-19

Group on Behalf of the Indian Stroke Association

Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic

Management of acute ischemic stroke in patients with COVID-19 infection: Insights from an international panel

Managing Non-COVID acute neurology amidst the pandemic: Challenges and work in progress

Tejedor E; en representación de los hospitales del Plan Ictus Madrid. Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan

Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic

COVID-19 and stroke: Experience in a Ghanaian healthcare system

Patient Characteristics and Outcomes Associated with Decline in Stroke Volumes During the Early COVID-19 Pandemic